Spinraza Side Effects. Last month, the Food and Drug Administration (FDA) approved the use of Spinraza as the first ever drug to “treat children and adults with spinal muscular atrophy”.
In announcing the new drug treatment, Dr. Billy Dunn, director of the agency’s Division of Neurology Products had this to say:
There has been a long-standing need for a treatment for spinal muscular atrophy, the most common genetic cause of death in infants, and a disease that can affect people at any stage of life. As shown by our suggestion to the sponsor to analyze the results of the study earlier than planned, the FDA is committed to assisting with the development and approval of safe and effective drugs for rare diseases and we worked hard to review this application quickly; we could not be more pleased to have the first approved treatment for this debilitating disease.
Continue reading Spinraza Side Effects: Kidney Damage and Bleeding Complications